Investing Profile

Greg Yap

InvestorVC

Partner at Menlo Ventures

menlovc.com/greg-yapPalo Alto, California

Your Intro Paths to Greg Yap

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Greg is a member of

GE Network

33 CONNECTIONS

The Aspen Institute Network

30 CONNECTIONS

Menlo Ventures Network

20 CONNECTIONS

Find Greg Yap on

Current Investing Position

Menlo Ventures Partner

Investment Range

$8.0M - $15.0M

Sweet Spot

$12.0M

Investments On Record

Current Fund Size

$500M

Greg Yap is on these Sector & Stage Rankings

Medical Devices (Seed)BioTech (Series B)Medical Devices (Series B)Medical Devices (Series A)BioTech (Seed)BioTech (Series A)Health IT (Series A)Health & Hospital Services (Series B)Health & Hospital Services (Series A)San Francisco Bay Area Digital Health (Series B)Health IT (Seed)Health IT (Series B)Digital Health (Series A)Digital Health (Seed)Health & Hospital Services (Seed)

Greg Yap's Investments On Record (21)

Company	StageDateRound Size	Total Raised
Aurora Therapeutics	SeedJan 2026$16M	$16M
Co-investors: Johnny Hu (Longitude Capital)
Chai Discovery	Series BDec 2025$130M Series AAug 2025$70M	$230M
Co-investors: Fred Ehrsam (Paradigm), Hemant Taneja (General Catalyst), Elena Viboch (General Catalyst), Lachy Groom (Physical Intelligence), Nitesh Banta (Stellar Capital), Annie Lamont (Oak HC/FT)
Cartwheel	Series BAug 2025$35M Series ASep 2023$20M	$75M
Co-investors: Daniel Levine (Accel), Holly Maloney McConnell (General Catalyst), Minnie Ingersoll (TenOneTen Ventures), Reva Nohria (General Catalyst Partners), Craig Cummings (Moonshots Capital), Raoul Maier (Eudemian Ventures, LLC), Samara Hernandez (Chingona Ventures), Lainy Painter (Craft Ventures), Sean Whitney (Craft Ventures), Elena (Lainy) Painter (Craft Ventures), Amjad Masad, Akshay Kothari, Drew Houston
Heidi Health	Series AMar 2025$17M	$88M
Co-investors: Brian Keil (Alumni Ventures ), Taylor Brandt (Headline (formerly e.ventures)), Sri Chandrasekar (Point72 Ventures), Michael Tolo (Blackbird Ventures Australia)
Clear Labs	Series DJan 2025$30M Series CMay 2021$60M Series UnknownMay 2020$21M Series BOct 2018$21M	$170M
Co-investors: Aydin Senkut (Felicis Ventures), Krishna Yeshwant (GV (Google Ventures)), Chris Sklarin (Alumni Ventures ), Karl Handelsman (Codon Capital), Miguel Valls (Alta Life Sciences), Kyle Kurpinski (Tencent Holdings)
Vilya	Series AJun 2024$21M	$71M
Co-investors: Steven Gillis (ARCH Venture Partners), Robert Nelsen (ARCH Venture Partners)
Xaira Therapeutics	Series AApr 2024$1B	$1B
Co-investors: Roelof Botha (Sequoia Capital), Scott Gottlieb (New Enterprise Associates (NEA)), Vikram Bajaj (Foresite Capital), Robert Nelsen (ARCH Venture Partners)
Delfi Diagnostics	Series BJul 2022$230M Series AJan 2021$100M SeedAug 2019$6M	$330M
Co-investors: Rishi Gupta (OrbiMed), Justin Kao (DFJ Growth)